Lucid's Investor Day event could put a charge in the stock
Skye Bioscience outlines 2026 milestones as nimacimab advances toward Phase IIb with new dosing strategy
Business
Blend Labs signals $28.5M–$30M Q1 2026 revenue target as pipeline shifts to bundled deals and AI adoption accelerates
Oracle targets rapid AI infrastructure expansion with $553B RPO and 32% gross margin in Q3 2026
Business
KVH targets $130M–$145M revenue in 2026 as LEO strategy accelerates and share buyback expands
SuRo Capital signals $5 to $6.50 per share NAV upside as AI infrastructure investments accelerate
Business
Higher oil prices will not lead to more U.S. production, Patterson-UTI CEO says
IDT raises 2026 adjusted EBITDA guidance to $147M-$149M as digital and AI initiatives accelerate
Motorsport Games signals platform scaling and targets console expansion following 30% revenue growth
Business